First the KAHC Spac ended last December and you would see that if you read down the page to 8.01
There is no deadline for 12-19-2023 as the Spac ended last December with the share redemption paid last year
Item 8.01
Other Events.
As a result of receiving stockholder approval of the foregoing proposals at the Special Meeting, the Company is proceeding with its previously announced intention to accelerate its business combination deadline to December 14, 2022, which date was the last date of trading of the Company’s securities on The New York Stock Exchange. After giving effect to the Company’s redemption of holders of Class A common stock that submitted a redemption election in connection with the Special Meeting, the mandatory redemption date for holders of any remaining outstanding shares of the Company’s Class A common stock, including shares that were included in the units issued in the Company’s initial public offering, will occur on or around December 23, 2022, and such shares of Class A common stock redeemed on the mandatory redemption date will receive a per share redemption price of approximately $10.08 to be paid from the Company’s trust account. Holders of the Company’s Class B shares will not receive any liquidating distribution from the Company’s trust account. The Company will complete its dissolution and liquidation in accordance with the terms of its amended and restated certificate of incorporation, as amended, and Delaware law.
That screen capture means absolutely nothing. So where is there a message from someone at LCY stating it? Even if LCY would go public it has nothing to do with FKA BioAmber.